A Report on Bovine Ephemeral Fever Virus in Turkey: Antigenic Variations of Different Strains of EFV in the 1985 and 2012 Outbreaks Using Partial Glycoprotein Gene Sequences.

We described the aetiological agents of outbreaks of bovine ephemeral fever (BEF) that occurred in 1985 and 2012 in Turkey, and identify mutations in the viruses from both outbreaks. Outbreaks have emerged periodically every 4-5 years in the same regions in Turkey. Because these regions are located in a subtropical climatic zone, good conditions for vector populations exist. The results of this study show that the BEFVs from outbreaks in Turkey vary significantly. Effective prevention will require a vaccine that contains BEFVs from different genetic clusters.

Infliximab-induced discoid lupus erythematosus.

Anti-tumor necrosis factor-alpha (TNF-α) immunotherapy is currently used in the treatment of various inflammatory diseases such as rheumatoid arthritis, psoriasis, psoriatic arthritis, ankylosing spondylitis and Crohn's disease. Infliximab is a chimeric monoclonal antibody that binds to transmembrane-bound and soluble TNF-α. Previously, a discoid lupus erythematosus-like eruption linked to its use was rarely reported in patients with rheumatoid arthritis. We present a case of rheumatoid arthritis which developed such an eruption after treatment with infliximab. The lesions resolved after the discontinuation of infliximab. In the present case, the clinical, serological and immunohistochemical features of our patient are discussed with the literature.

Molecular characteristics of bovine virus diarrhoea virus 1 isolates from Turkey: approaches for an eradication programme.

Forty pestivirus isolates sampled from cattle in Turkey between 2002 and 2007 were characterized according to 5' untranslated region (5'UTR) sequences and autoprotease (N(pro) ) gene sequences. The sampling of Bovine virus diarrhoea viruses (BVDVs) from 15 farms in five different regions indicated that BVDV 1-l (18/40, 45%) was the predominant genotype in Turkey; the samples also contained the genotypes 1-f (10/40, 25%), 1-b (7/40, 17.5%), 1-d (3/40, 7.5%), and 1-a (2/40, 5%), respectively.

Virological and serological studies on the role of PI-3 virus, BRSV, BVDV and BHV-1 on respiratory infections of cattle. I. The detection of etiological agents by direct immunofluorescence technique.

Nasal cells extracted from nasal swabs obtained from 95 cattle with signs of respiratory disease, out of eleven different herds, were tested for BHV-1, PI-3 virus, BRSV and BVDV using direct immunofluorescence technique. Viral antigen positive samples were detected in seven out of eleven herds examined. Of the 95 individual diseased cattle, 19 were found positive for at least one viral antigen. It was found that especially BHV-1 and PI-3 virus are important causative agents in cattle respiratory disease, both or in combination with other pathogenic agents. Multiple infection in virologically positive herds were observed in six (9.8%) of 61 animals tested. The findings reveal that single or multiple infections of selected viruses may be present in an important range in cattle and that direct immunofluorescence technique as a rapid method, based on the detection of viral antigen in nasal swab samples, is useful to establish the viral aetiology of acute bovine respiratory disease caused by these viruses, particularly in the diagnosis of mixed viral infections.

Antibody prevalence of caprine arthritis encephalitis virus (CAEV) in goats in Turkey.

In this study, a serological survey in goat herds for antibodies against Caprine Arthritis Encephalitis Virus (CAEV) in Turkey is described. 808 serum samples were collected from three state farms and seven private flocks in different regions of Turkey. The serologic examination was performed by Agar Gel Immunodiffusion (AGID) technique. 16 (1.9%) out of 808 sera deriving from two state farms (n = 14) and one private herd (n = 2) were found to be serologically positive. The findings are discussed with regard to the relatively low prevalence of CAEV in Turkey, age and race dependency and the kind of origin of the serologically screened animals.

Sero-epidemiological and pathological studies on enzootic bovine leukosis in Turkey.

The prevalence of enzootic bovine leukosis (EBL) in Turkey was investigated by serological screenings using the agargel immunodiffusion test (AGID). A total of 4,047 blood samples obtained from 2,780 cattle between one and 14 years of age and taken in 6-8 month-intervals in three dairy farms were tested for the presence of EBL-specific antibodies. A high prevalence of EBL-sero-positive animals was found amongst cattle in two of the farms. Furthermore, recommendations based upon the regulation implemented by an expert group of the European Commission and considering the local dairy management conditions were presented.

A seroepidemiologic study of bovine respiratory syncytial virus (BRSV) in Turkey.

In this study, a survey of cattle for neutralizing antibodies to respiratory syncytial virus (RSV) in Turkey is presented. 490 serum samples were collected from several state farms and some private flocks in different regions of Turkey. The serologic examination was done by the microtiter serum-neutralization technique. In this report, a positive serum antibody titer at dilutions of 1:2 was demonstrated in 226 (46.12%) of the 490 sera tested.

[Determination of antibody levels against coxsackie B virus type 2 and type 3 in sera from blood donors using the microneutralization test]. / Kan donörlerine ait serumlarda Coxsackie B virus tip-2 ve tip-3'e karsi antikor düzeylerinin mikronötralizasyon yöntemi ile arastirilmasi.

The presence of antibodies and their titers against Coxsackie B virus type 2 and type 3 (CBV-2 and CBV-3) have been investigated in 208 blood donor's sera obtained from blood Bank of Gülhane Military Medical Academy. The seropositivity against Coxsackie B virus type 2 and type 3 have been determined 59.1% (123/208) and 7.2% (15/208) respectively. These findings suggest that Coxsackie B virus type 2 infections may be present more widely than Coxsackie B virus type 3 infections in our country.

[Respiratory syncytial virus antibody levels in the 13-25 age group of healthy people using a microneutralization test]. / 13-25 yas grubundaki saglikli kisilerde respiratory syncytial virus antikor düzeylerinin mikronötralizasyon testi ile arastirilmasi.

In this study antibody levels to Respiratory Syncytial virus were investigated in 181 serum samples obtained from healthy individuals by using microneutralization test. 25 out of 181 sera (13.8%) were found positive at 1/5 dilution. Serum neutralization50 (SN50) value of these sera were detected at different titers which varied from 1/7.08 to 1/79.5.